CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Balance Sheet
NYSEARCA:CLDI - NYSE Arca - US3207033099 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.56M | 1.95M | 93.90K | 1.06M | N/A | |||
| Receivables | 50.00K | N/A | 900.00 | N/A | N/A | |||
| Other Current Assets | 878.00K | 2.35M | 414.00K | 603.00K | 93.00K | |||
| Total Current Assets | 11.49M | 4.30M | 786.00K | 2.74M | 513.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.43M | 5.34M | 1.09M | 585.00K | 723.00K | |||
| Investments And Advances | N/A | 230.00K | 725.00K | 66.00K | 616.00K | |||
| Other Non-Current Assets | 144.00K | 143.00K | 0.00 | 280.90K | N/A | |||
| Total Non-Current Assets | 3.58M | 5.72M | 1.81M | 651.00K | 1.34M | |||
| TOTAL ASSETS | 15.06M | 10.02M | 2.60M | 3.39M | 1.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 2.96M | 4.48M | 1.86M | |||
| Current Portion Of LT Debt. | 1.20M | 888.00K | 2.54M | 568.00K | 3.14M | |||
| Accrued Expenses | 3.02M | 6.47M | 5.39M | 3.60M | 1.81M | |||
| Accounts Payable | 1.20M | 2.80M | 2.12M | 510.00K | 822.00K | |||
| Other Current Liabilities | 7.00K | 81.00K | 29.98M | 16.80M | 1.25M | |||
| Total Current Liabilities | 5.43M | 10.23M | 42.99M | 25.96M | 8.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 729.00K | 2.28M | 142.00K | 38.00K | 6.37M | |||
| Other Non-Current Liabilities | 1.61M | 5.75M | 305.00K | 5.00K | 72.00K | |||
| Total Non-Current Liabilities | 2.70M | 8.02M | 447.00K | 43.00K | 6.44M | |||
| TOTAL LIABILITIES | 8.12M | 18.25M | 43.44M | 26.00M | 15.33M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -126.70M | -99.57M | -70.36M | -44.93M | -34.44M | |||
| Additional Paid In Capital | 133.66M | 91.38M | 19.93M | 13.32M | 11.95M | |||
| Minority Interest | 358.00K | N/A | N/A | N/A | N/A | |||
| Common Shares | 3.00K | 4.00K | 9.60M | 9.00M | 9.00M | |||
| Other Shareholders' Equity | -26.00K | -47.00K | -14.00K | -1.00K | 6.00K | |||
| Shares Outstanding | 31.79M | 5.35M | 4.55M | 4.55M | 45.45M | |||
| Tangible Book Value per Share | 0.22 | -1.54 | -11.10 | -6.96 | -0.49 | |||
| Total Shareholders' Equity | 6.94M | -8.23M | -40.84M | -22.61M | -13.48M | |||
| TOTAL LIABILITIES AND EQUITY | 15.06M | 10.02M | 2.60M | 3.39M | 1.85M | |||
| Statistics | ||||||||
| Debt/Equity | 0.11 | -0.28 | -0.08 | -0.20 | -0.61 | |||
| Current Ratio | 2.12 | 0.42 | 0.02 | 0.11 | 0.06 | |||
| Return On Assets (ROA) | -143.22% | -291.61% | -979.09% | -322.41% | -428.56% | |||
| Return On Equity (ROE) | -310.83% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21